UBS Upgrades Jazz Pharmaceuticals to Buy, Sets $307 Target
UBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
Explore criteria to identify altcoins safe for long-term holding, including fundamentals, liquidity, and community support. Start evaluating with confidence.
27,729 articlesUBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
A new Nasdaq-100 strategy fund began paying weekly Friday distributions, targeting a 40% yield and challenging the tr...
A surge in people choosing to rent is changing the game for real estate investors. This article breaks down loan stra...
BingEx reports Q1 2026 results that reveal both momentum and headwinds. This article breaks down the key numbers, exp...
Two AI hardware names—Astera Labs and Navitas Semiconductor—shine for investors through very different revenue paths....
Netflix’s strategic shift sent a ripple through the market, highlighting how breakup fees and deal terms shape stream...
Three leading space names moved higher in a risk-on trading session, with AST SpaceMobile, Rocket Lab and Planet Labs...
Aehr Test Systems stock jumped 46% in a single month amid upbeat contract news and rising demand for burn-in testing....
A pivotal moment in AI memory stocks could propel a leading name higher after Micron's earnings. This article breaks ...
Fastly stock already doubled this year, leaving many investors wondering if the rally can continue. This guide breaks...
As a new Fed chair, chair kevin warsh will confront two high-stakes tests in just 100 days. One test centers on polit...
Centuri Holdings ends 2025 with a booming backlog and falling debt, yet investors face a high bar to justify lofty va...